Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Saved in:
| Title: | Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial. |
|---|---|
| Authors: | Tromp J; Saw Swee Hock School of Public Health, National University of Singapore & the National University Health System, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.; George Institute for Global Health, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Angermann CE; Comprehensive Heart Failure Centre and Department of Medicine I (Cardiology), University and University Hospital of Würzburg, Würzburg, Germany., Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center and Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA., Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA., Ponikowski P; Institute of Heart Diseases, Medical University, Wroclaw, Poland., Biegus J; Institute of Heart Diseases, Medical University, Wroclaw, Poland., Ferreira JP; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Nassif ME; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA., Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Blatchford JP; Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Steubl D; Boehringer Ingelheim International, Ingelheim, Germany.; Department of Nephrology, Klinikum rechts der Isar, Faculty of Medicine, Technical University, Munich, Germany., Voors AA; University of Groningen Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2024 Apr; Vol. 26 (4), pp. 963-970. Date of Electronic Publication: 2024 Apr 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38572654 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tromp+J%22">Tromp J</searchLink>; Saw Swee Hock School of Public Health, National University of Singapore & the National University Health System, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Kosiborod+MN%22">Kosiborod MN</searchLink>; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.; George Institute for Global Health, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Angermann+CE%22">Angermann CE</searchLink>; Comprehensive Heart Failure Centre and Department of Medicine I (Cardiology), University and University Hospital of Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Collins+SP%22">Collins SP</searchLink>; Department of Emergency Medicine, Vanderbilt University Medical Center and Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Teerlink+JR%22">Teerlink JR</searchLink>; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ponikowski+P%22">Ponikowski P</searchLink>; Institute of Heart Diseases, Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Biegus+J%22">Biegus J</searchLink>; Institute of Heart Diseases, Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Ferreira+JP%22">Ferreira JP</searchLink>; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Nassif+ME%22">Nassif ME</searchLink>; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Psotka+MA%22">Psotka MA</searchLink>; Inova Heart and Vascular Institute, Falls Church, VA, USA.<br /><searchLink fieldCode="AU" term="%22Brueckmann+M%22">Brueckmann M</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Blatchford+JP%22">Blatchford JP</searchLink>; Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Steubl+D%22">Steubl D</searchLink>; Boehringer Ingelheim International, Ingelheim, Germany.; Department of Nephrology, Klinikum rechts der Isar, Faculty of Medicine, Technical University, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; University of Groningen Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887595%22">European journal of heart failure</searchLink> [Eur J Heart Fail] 2024 Apr; Vol. 26 (4), pp. 963-970. <i>Date of Electronic Publication: </i>2024 Apr 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0844 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213889842%22">13889842 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Heart Fail <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38572654 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ejhf.3218 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 963 Titles: – TitleFull: Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tromp J – PersonEntity: Name: NameFull: Kosiborod MN – PersonEntity: Name: NameFull: Angermann CE – PersonEntity: Name: NameFull: Collins SP – PersonEntity: Name: NameFull: Teerlink JR – PersonEntity: Name: NameFull: Ponikowski P – PersonEntity: Name: NameFull: Biegus J – PersonEntity: Name: NameFull: Ferreira JP – PersonEntity: Name: NameFull: Nassif ME – PersonEntity: Name: NameFull: Psotka MA – PersonEntity: Name: NameFull: Brueckmann M – PersonEntity: Name: NameFull: Blatchford JP – PersonEntity: Name: NameFull: Steubl D – PersonEntity: Name: NameFull: Voors AA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1879-0844 Numbering: – Type: volume Value: 26 – Type: issue Value: 4 Titles: – TitleFull: European journal of heart failure Type: main |
| ResultId | 1 |
